Browse > Article

Preliminary Results of Phase I/II Study of Simultaneous Modulated Accelerated (SMART) for Nasopharyngeal Carcinoma  

Park Jin-Hong (Department of Radiation Oncology, College of Medicine, University of Ulsan, Asan Medical Center)
Back Geum-Mun (Department of Radiation Oncology, College of Medicine, University of Ulsan, Asan Medical Center)
Yi Byong-Yong (Department of Radiation Oncology, College of Medicine, University of Ulsan, Asan Medical Center)
Choi Eun-Kyung (Department of Radiation Oncology, College of Medicine, University of Ulsan, Asan Medical Center)
Ahn Seung-Do (Department of Radiation Oncology, College of Medicine, University of Ulsan, Asan Medical Center)
Shin Seong-Soo (Department of Radiation Oncology, College of Medicine, University of Ulsan, Asan Medical Center)
Kim Jung-Hun (Department of Radiation Oncology, College of Medicine, University of Ulsan, Asan Medical Center)
Kim Sang-Yoon (Department of Otolaryngology, College of Medicine, University of Ulsan, Asan Medical Center)
Lee Bong-Jae (Department of Otolaryngology, College of Medicine, University of Ulsan, Asan Medical Center)
Nam Soon-Yuhl (Department of Otolaryngology College of Medicine, University of Ulsan, Asan Medical Center)
Choi Seung-Ho (Department of Otolaryngology College of Medicine, University of Ulsan, Asan Medical Center)
Kim Seung-Bae (Department of Medical Oncology, College of Medicine, University of Ulsan, Asan Medical Center)
Lee Sang-Wook (Department of Radiation Oncology, College of Medicine, University of Ulsan, Asan Medical Center)
Publication Information
Radiation Oncology Journal / v.24, no.1, 2006 , pp. 1-10 More about this Journal
Abstract
Puroose: To present preliminary results of intensity-modulated radiotherapy (IMRT) using the simultaneous modulated accelerated radiation therapy (SMART) boost technique in patients with nasopharyngeal carcinoma (NPC). Materials and Methods: Twenty patients who underwent IMRT for non-metastatic NPC at the Asan Medical Center between September 2001 and December 2003 were prospectively evaluated. IMRT was delivered using the 'step and shoot' SMART technique at prescribed doses of 72 Gy (2.4 Gy/day) to the gross tumor volume (GTV), 60 Gy (2 Gy/day) to the clinical target volume (CTV) and metastatic nodal station, and 46 Gy (2 Gy/day) to the clinically negative neck region. Eighteen patients also received concurrent chemotherapy using cisplatin once per week. Results: The median follow-up period was 27 months. Nineteen patients completed the treatment without interruption; the remaining patient interrupted treatment for 2 weeks owing to severe pharyngitis and malnutrition. Five patients (25%) had RTOG grade 3 mucositis, whereas nine (45%) had grade 3 pharyngitis. Seven patients (35%) lost more than 10% of their pretreatment weight, whereas 11 (55%) required intravenous fluids and/or tube feeding. There was no grade 3 or 4 chronic xerostomia. All patients showed complete response. Two patients had distant metastases and loco-regional recurrence, respectively. Conclusion: IMRT using the SMART boost technique allows parotid sparing, as shown clinically and by dosimetry, and may also be more effective biologically. A larger population of patients and a longer follow-up period are needed to evaluate ultimate tumor control and late toxicity.
Keywords
Concurrent chemoradiotherapy; Intensity modulated radiotherapy; Nasopharyngeal carcinoma;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Butler EB, Teh BS, Grant WH 3rd, et al. Smart (simultaneous modulated accelerated radiation therapy) boost: a new accelerated fractionation schedule for the treatment of head and neck cancer with intensity modulated radiotherapy. Int J Radiat Oncol Biol Phys 1999;45:21-32   DOI   ScienceOn
2 Wu Q, Manning M, Schmidt-Ullrich R, et al. The potential for sparing of parotids and escalation of biologically effective dose with intensity-modulated radiation treatments of head and neck cancers: a treatment design study. Int J Radiat Oncol Biol Phys 2000;46: 195-205   DOI   ScienceOn
3 Boyer AL, Geis P, Grant W. et al, Modulated beam conformal therapy for head and neck tumors. Int J Radiat Oncol Biol Phys 1997;39:227-236   DOI   ScienceOn
4 Xia P, Verhey LJ. Multileaf collimator leaf sequencing algorithm for intensity modulated beams With multiple static segments. Med Phys 1998;25:1424-1434   DOI   ScienceOn
5 Nam SY, Lee SW. Im KC. et al. Early evaluation of the response to radiotherapy of patients with squamous cell carcinoma of the head and neck using 18FDG-PET. Oral Oncol 2005;41 :390-395   DOI   ScienceOn
6 Chao KS, Bosch WR, Mutic S. et al. A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 2001 :49:1171-1182   DOI   ScienceOn
7 Horiot JC. Bontemps P, van den Bogaert W, et al. Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial. Radiother Oncol 1997;44:111-121   DOI   ScienceOn
8 AI-Sarraf M. LeBlanc M, Giri PG, et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099. J Clin Oncol 1998;16:1310-1317   DOI
9 Vikram B, Mishra UB, Strong EW, et al. Patterns of failure in carcinoma of the nasopharynx: I. Failure at the primary site. Int J Radiat Oncol Biol Phys 1985;11:1455-1459   DOI   ScienceOn
10 Mohan R, Wu Q, Manning M, et al. Radiobiological considerations in the design of fractionation strategies for intensity-modulated radiation therapy of head and neck cancers. Int J Radiat Oncol Biol Phys 2000:46:619-630   DOI   ScienceOn
11 Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481   DOI
12 Som PM, Curtin HD, Mancuso AA. The new imaging-based classification for describing the location of lymph nodes in the neck with particular regard to cervical lymph nodes in relation to cancer of the larynx. ORL J Otorhinolaryngol Relat Spec 2000;62:186-198   DOI   ScienceOn
13 Lee N, Xia P, Quivey JM, et al. Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. Int J Radiat Oncol Biol Phys 2002;53:12-22   DOI   ScienceOn
14 Chao K. Dose prescription and target delineation for nodal volume. Philadelphia, PA: Lippincott Co. 2003
15 Marks JE, Bedwinek JM, Lee F, et al. Dose-response analysis for nasopharyngeal carcinoma: an historical perspective. Cancer 1982;50: 1042-1050   DOI   ScienceOn
16 Som PM, Curtin HD, Mancuso AA. An imaging-based classification for the cervical nodes designed as an adjunct to recent clinically based nodal classifications. Arch Otolaryngol Head Neck Surg 1999;125:388-396   DOI
17 Eisbruch A. Intensity-modulated radiotherapy of head-and-neck cancer: encouraging early results. Int J Radiat Oncol Biol Phys 2002;53:1-3   DOI   ScienceOn
18 Fleming I, Cooper J, Henson D. AJCC cancer staging manual. 5th ed. Philadelphia: Lippincott-Raven. 1997
19 Fu KK, Pajak TF, Trotti A, et al. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys 2000:48:7-16   DOI   ScienceOn
20 Wolden SL, Chen WC, Pfister DG, et al. Intensity-modulated radiation therapy (IMRT) for nasopharynx cancer: update of the memorial Sloan-kettering experience. lnt J Radiat Oncol Biol Phys 2006;64:57-62   DOI   ScienceOn
21 Wolden SL, Zelefsky MJ, Hunt MA, et al. Failure of a 3D conformal boost to improve radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2001;49:1229-1234   DOI   ScienceOn
22 Ma L, Boyer AL, Xing L. et al, An optimized leaf-setting algorithm for beam intensity modulation using dynamic multileaf collimators. Phys Med Biol 1998:43:1629-1643   DOI   ScienceOn
23 Astreinidou E. Dehnad H, Terhaard CH. et al. Level II lymph nodes and radiation-induced xerostomia. Int J Radiat Oncol Biol Phys 2004;58:124-131   DOI   ScienceOn
24 Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995;31:1341-1346   DOI   ScienceOn